Victims have reported M.Plus Life Sciences AG through direct victim submissions through SARFund. The case is classified as a clone-of-a-real-exchange front and was opened on the SARFund registry once corroboration thresholds were met.

Across the verified submissions, three red flags repeat: the broker rebranded under multiple domains in succession, required upfront deposits routed through obscure custodial wallets, and blocked withdrawal requests. None of these are unique to M.Plus Life Sciences AG — they are the structural fingerprint of this scam typology.

Public chatter on direct victim submissions through SARFund, Facebook group reports and Telegram channel testimonials shows the same recurring complaint structure: deposits go in, dashboard “earnings” appear, withdrawal requests trigger fee demands, and contact eventually goes silent.

What victims should do

If you deposited funds with this platform, file a claim with SARFund as soon as possible. Provide transaction hashes, wallet addresses, deposit dates, and any communication with the operator (Telegram, WhatsApp, email). The fresher the evidence, the higher the chance of a successful trace.

Why the recovery partner is masked

Listing the partner publicly creates two problems: it tips off perpetrators, who then accelerate fund-laundering, and it invites recovery-scam impersonators to clone the partner brand. Both happen often enough that masking is the only defensible default.

Suspect you were affected by M.Plus Life Sciences AG? Submit your claim evidence and SARFund will route it to the partner working this case. No upfront fees, no obligation, no recovery guarantee — just verification and coordination.

SARFund does not guarantee recovery. All recovery actions are conducted by independent partners. Submission is free. SARFund is an intermediary case registry, not a recovery firm.